Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics Inc (NQ: NRIX )

19.41 +0.48 (+2.54%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 396,383
Open 19.00
Bid (Size) 17.31 (1)
Ask (Size) 22.40 (13)
Prev. Close 18.93
Today's Range 18.81 - 20.02
52wk Range 4.220 - 22.44
Shares Outstanding 47,147,781
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
Via Benzinga
Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
The Nasdaq and S&P 500 backed off highs. The Dow regained a key level. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities

Performance

YTD
+89.92%
+89.92%
1 Month
+20.93%
+20.93%
3 Month
+33.04%
+33.04%
6 Month
+101.35%
+101.35%
1 Year
+93.13%
+93.13%

More News

Read More
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Via Benzinga
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights
Via Benzinga
Key Takeaways From Nurix Therapeutics Analyst Ratings
Via Benzinga
Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial
Via Investor's Business Daily
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know
Via Benzinga
Analyst Scoreboard: 7 Ratings For Nurix Therapeutics
Via Benzinga
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Decoding 4 Analyst Evaluations For Nurix Therapeutics
Via Benzinga
Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
From Toll Brothers, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.